Cytori Therapeutics Inc. shares (NASDAQ:CYTX) headed skyward Tuesday morning after the company disclosed a deal with Chinese firm Lorem Vascular to commercialize Cytori cell therapy in the cardiovascular, renal and diabetes markets in China, Hong Kong, Malaysia, Singapore and Australia.